Funded Local Who is raising money in your own backyard?

VANCOUVER, British Columbia--(BUSINESS WIRE)--Response Biomedical Corporation (TSX: RBM, OTCBB: RPBF) announced today the signing of a subscription agreement providing for the sale of C$8 million of its common shares to funds affiliated with OrbiMed Advisors, LLC. The closing of the private placement is subject to receipt of all necessary regulatory approvals, including the approval of the Toronto Stock Exchange (“TSX”) and the shareholders of the Company.

GreenAngel Energy Corporation (“GreenAngel”) (TSX-V: GAE) reports that Delaware Power Systems Inc (“DPS”) and Light-Based Technologies Inc. (“LBT”), two of its investee companies have closed financing rounds totaling $6 million dollars.

GreenAngel Energy Corporation (“GreenAngel”) (TSX-V: GAE) has entered into a Memorandum of Understanding (“MOU”) with Rapid Electric Vehicles Inc. (“REV”) to raise up to $5 million in several tranches during 2010.

Vancouver, BC – August 31, 2009 – Nexterra Systems Corp. (www.nexterra.ca) a leading supplier of advanced biomass gasification systems announced today it has received $7.7M in funding from the BC Bioenergy Network (BCBN), Sustainable Development Technology Canada (SDTC), the National Research Council Canada Industrial Research Assistance Program (NRC-IRAP), and Ethanol BC.

VANCOUVER, Jul 24, 2009 -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that it has completed its registered direct offering, previously announced on July 20, 2009, of 475,000 shares of its common stock to institutional investors at a price of $20.00 per share, for gross proceeds to the Company of approximately $9.5 million. The $20 offering price represented a 3.5% discount to the closing price on July 17, 2009, the last trading day prior to announcement.

VANCOUVER, Jul 20, 2009 (Canada NewsWire via COMTEX News Network) -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today it has entered into purchase agreements with certain institutional investors for the sale of 475,000 shares of its common stock at a price of $20 per share through a registered direct offering. The transaction is expected to provide gross proceeds of $9.5 million to OncoGenex before deducting costs associated with the offering, and will be used primarily for manufacturing activities and general corporate purposes.

Company Will Use New Funding for Global Expansion of Sales and Marketing, Continued R&D

November 4, 2008, Vancouver, BC — Digital Payment Technologies Corp. (DPT), a leading supplier of advanced multi-space parking meters and revenue-management solutions for the global parking industry, is pleased to announce a $3,000,000 investment and conditional commitment for an additional $3,000,000 into the company by C.A. Bancorp Inc. (TSX: BKP) (“C.A. Bancorp”)

CON-SPACE Communications Ltd. (the “Company” or “CON-SPACE”) (TSX-V: CCB), entered into a loan agreement (the “Loan Agreement”) dated April 11, 2007 with Turret Oy Ab (“Turret”), a Finnish company, with respect to a CDN$6,000,000 loan made by Turret to the Company, the proceeds of which were utilized for the purchase of the Search Systems Inc. Under the Loan Agreement, there are a number of covenants that the Company must meet, including an earnings covenant to be met beginning at the end of its 2008 fiscal year, namely June 30, 2008.

VANCOUVER, Oct. 14 - Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) (the "Company") today announced that it has entered into an agreement with Haywood Securities Inc., as agent, pursuant to which the Company has agreed to offer for sale, on a best efforts basis and by private placement, an aggregate of 30,555,556 units at a price of $0.18 per unit, each unit consisting of one common share and one-half of one common share purchase warrant, for gross proceeds of approximately $5.5 million.